Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Feb 2026, Mar 2026, May 2026 and Jun 2026.
- Largest single sale: $8.9M (117,604 shares) of Ionis Pharmaceuticals Inc on Mar 9, 2026. Filing
- Last sale before this period: Oct 6, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | Chief Executive Officer, Director | Jan 3, 2012 | Sep 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Ionis Pharmaceuticals Inc: 98 shares in other transactions. 1 filing: 1
- Jun 26, 2026, Ionis Pharmaceuticals Inc: sold 50,000 shares for $4.0M, under a disclosed plan; 50,000 shares acquired by exercising options. 1 filing: 1
- Jun 25, 2026, Ionis Pharmaceuticals Inc: sold 21,072 shares for $1.7M, under a disclosed plan; 21,072 shares acquired by exercising options. 1 filing: 1
- Jun 24, 2026, Ionis Pharmaceuticals Inc: sold 14,565 shares for $1.1M, under a disclosed plan; 14,565 shares acquired by exercising options. 1 filing: 1
- May 14, 2026, Ionis Pharmaceuticals Inc: sold 3,220 shares for $253K, under a disclosed plan; 3,220 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.